-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
Volition Veterinary – Key Opinion Leader Roundtable
- Share
- Tweet
- Share on Facebook
- Share
A short video summarising Volition Veterinary’s recent Key Opinion Leader roundtable, which involved preview of data presented at the Veterinary Cancer Society Meeting.
Volition Veterinary Chief Medical Officer, Heather Wilson-Robles, was joined by Dr. Tim Fan, Dr. David Vail, and Dr. Sue Ettinger. Watch the video to hear from the experts.
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields